English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

In this issue of the Journal, Tarantino et al .[1][1] describe their experience with the use of romiplostim to treat children with persistent immune thrombocytopenia (ITP). The results of this study also have implications for management of children who present with ITP.[1][1]Eighty to 90% of

The child with immune thrombocytopenia: to treat or not to treat, is that still the question?